Phosphate Buffer 18-24 Months Thymosin Alpha 1 Caha-Ha Hydroxylapatite Filler

Name: Phosphate Buffer 18-24 Months Thymosin Alpha 1 Caha-Ha Hydroxylapatite Filler
Brand: SHANGHAI BIOHA BIOLOGICAL TECHNOLOGY COMPANY LIMITED
SKU: 2291335895

Shanghai, ChinaSHANGHAI BIOHA BIOLOGICAL TECHNOLOGY COMPANY LIMITED

US$20.00-45.00

1 Piece

Sample price:US$45.00/piece.Request sample

Product profile

Customization

Available

Product Name

Calcium Hydroxyapatite Dermal Filler

Keywords

Injectable Calcium Hydroxyapatite Filler

Model NO.

1x 1.0ml Syringe

OEM & ODM Custom

Logo Custom

Main Material

Calcium Hydroxyapatite (Caha) Microspheres

Caha Concentration

30% (25-45 Microns Diameter)

Hyaluronic Acid Content

70% Cross-Linked Sodium Hyaluronate Gel

Anesthetic Agent

Lidocaine Hydrochloride (3mg/Ml)

Buffer Solution

Phosphate Buffer

Duration of Effect

18-24 Months

Transport Package

Export Standard Carton Packaging

Specification

Standard Specifications or Customized

Trademark

Cahaderm®

Origin

Shanghai, China

Production Capacity

1000000pieces/Year

Company profile

Importers and ExportersHigh Repeat Buyers ChoiceYears of Export Experience

SHANGHAI BIOHA BIOLOGICAL TECHNOLOGY COMPANY LIMITED

Shanghai, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableAverage Response Time: ≤11.25h

AI-Powered supplier vetting

SummarySHANGHAI REYOUNGEL MEDICAL TECHNOLOGY COMPANY LIMITED is a China-based limited company in Shanghai described as both a trading company and manufacturer/factory. Its listed products are filler cannulas, meso needles, and dermal fillers. The supplier reports ISO 13485 certification, more than 10 production lines, 11–20 years of total R&D engineer experience, and sales in more than 30 countries. Export sales account for 90%, and it has self-operated import and export rights. However, the provided information does not establish current audit validity, audit performance, after-sales capability, customization services, customer references, financial credibility, raw-material traceability, or specific R&D/ODM/OEM capabilities. Several operational fields are explicitly marked unknown.

Supplier typeThe supplier is identified as a factory and, more specifically, as both a trading company and manufacturer/factory. It is a China-based limited company operating in Shanghai, indicating manufacturing involvement but also a trading function.

CertificationsThe supplier lists ISO 13485 certification, and a TUV Rheinland audit record is provided with a stated period from August 22, 2024 to August 21, 2025. However, the audit evaluation result is recorded as 0, and the provided information does not clarify the meaning of that result or establish current certification validity.

R&D capabilityThe supplier states that it uses technological breakthroughs, emphasizes technical innovation, conducts market research, listens to customer feedback, and engages in continuous product development. It also reports 11–20 years of total R&D engineer experience, but specific new-product output and SDK-related R&D capability are unknown.

Production capacityThe supplier is identified as a manufacturer/factory, lists more than 10 production lines, and offers filler cannulas, meso needles, and dermal fillers. These facts explicitly support manufacturing capacity, although the audit evaluation result of 0 is not explained in the provided information.

Client casesThe supplier states that its products are sold in more than 30 countries and recognized by customers. However, collaboration with Fortune 500 companies is unknown, and no named customers, customer projects, or verifiable case details are provided.